A meta-analysis further indicated that higher NF-κB expression in NSCLC cells is associated with shorter overall survival of NSCLC patients and is closely correlated with tumor stage, lymph node metastasis, and 5-year overall survival [27]. This evidence concerns the gene NFKB1 and neoplasm.